What is NDC 64980-705?

64980-705 is the product NDC for Fexmid (cyclobenzaprine hydrochloride), Cyclobenzaprine hydrochloride 7.5 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Fexmid (Cyclobenzaprine Hydrochloride).

Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Fexmid?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Fexmid NDC 64980-705 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)64980-705Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64980-0705Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
64980-705-01	64980070501	100 TABLET in 1 BOTTLE (64980-705-01)Marketed from Mar 10, 2025
64980-705-50	64980070550	500 TABLET in 1 BOTTLE (64980-705-50)Marketed from Mar 10, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fexmid
Generic name (nonproprietary): cyclobenzaprine hydrochloride
Active ingredients: Cyclobenzaprine hydrochloride — 7.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 64980
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218936
Marketing start: Mar 10, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 64980-705_8ebfc7eb-5a9a-4f3d-af2c-370732df074fSPL ID 8ebfc7eb-5a9a-4f3d-af2c-370732df074fSPL set ID 41838966-de0b-4855-83b8-2ff6c764ed1fRxCUI 828299, 828301UNII 0VE05JYS2P
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464980070501 followed by a unit qualifier and the quantity

Package 64980-0705-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 7, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fexmid ® is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living. Fexmid ® should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. Fexmid ® …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 64980-705

What is NDC 64980-705?: 64980-705 is the product NDC for Fexmid (cyclobenzaprine hydrochloride), Cyclobenzaprine hydrochloride 7.5 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Fexmid (Cyclobenzaprine Hydrochloride).
What is the active ingredient?: Cyclobenzaprine hydrochloride.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Fexmid?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 218936

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218936
Product	Strength	Form · route	Labeler	Product NDC
Cyclobenzaprine Hydrochloride	Cyclobenzaprine hydrochloride 10 mg/1	TabletOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8665
Cyclobenzaprine Hydrochloride	Cyclobenzaprine hydrochloride 5 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-655
Cyclobenzaprine Hydrochloride	Cyclobenzaprine hydrochloride 10 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-657
Cyclobenzaprine Hydrochloride	Cyclobenzaprine hydrochloride 10 mg/1	TabletOral	REMEDYREPACK INC.	70518-4692
Cyclobenzaprine Hydrochloride	Cyclobenzaprine hydrochloride 10 mg/1	TabletOral	Bryant Ranch Prepack	71335-2666

Fexmid (Cyclobenzaprine hydrochloride) NDC 64980-705